Author: Anonymous

38. Heparin therapy is most effective in the __________ state of DIC with evident vascular thrombosis.

31. Clinical manifestations of heterozygous AT-III deficiency (such as thrombotic episodes before age 40) may occur in association with:

31. Clinical manifestations of heterozygous AT-III deficiency (such as thrombotic episodes before age 40) may occur in association with:

51. Advantages of the APTT over the anti-factor Xa chromogenic assay for monitoring intravenous heparin therapy include all of the following except:

55. Which laboratory test is used to monitor low-molecular-weight heparin therapy?

4. Activated protein C is capable of degrading which activated plasma factors in the presence of its cofactor protein S?

23. The most frequently encountered inherited thrombotic disorder in Caucasians (people of European descent) is _____________________.

11. Clinical histories of patients with hemophilia A may indicate all of the following symptoms except:

5. Factor VIII:vWF is the carrier protein of the factor VIII complex and serves to concentrate __________ present in small amounts to the site of the injury.

38. Which of the following is not one of the criteria recommended by the International Society on Thrombosis and Hemostasis for the diagnosis of LA?